31
Jan

With the help of Syncona, the Wellcome Trust’s venture arm, Oxford University spinout NightstaRx has $20 million and a plan to develop gene therapies for degenarative eye conditions.

…read more

Source: Wellcome ponies up $20M to kick-start an Oxford spinoff

    

0 No comments